Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation

Lookup NU author(s): Dr Catherine Drummond, Arman Esfandiari, Dr Xiaohong Lu, Dr Claire Hutton, Dr Jennifer Jackson, Dr Karim BennaceurORCiD, Qing Xu, Emeritus Professor Herbie Newell, Dr Ian HardcastleORCiD, Professor Roger Griffin, Emeritus Professor John LunecORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Drummond CJ, Esfandiari A, Liu J, Lu X, Hutton C, Jackson J, Bennaceur K, Xu Q, Makimanejavali AR, Bello FD, Piergentili A, Newell DR, Hardcastle IR, Griffin RJ, Lunec J

Publication type: Article

Publication status: Published

Journal: Oncotarget

Year: 2016

Volume: 7

Issue: 29

Pages: 46203-46218

Online publication date: 15/06/2016

Acceptance date: 29/05/2016

Date deposited: 04/07/2016

ISSN (electronic): 1949-2553

Publisher: Impact Journals LLC

URL: http://dx.doi.org/10.18632/oncotarget.10073

DOI: 10.18632/oncotarget.10073

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder referenceFunder name
C0190R4011Newcastle University & Northern Institute for Cancer Research
C240/A15751Cancer Research UK
C27826/A11524Cancer Research UK
RES0190/7368DePPICT FP6 Commission of the European Communities Programme

Share